Head of biotech research center aims for 'stable financial base' - The Business Review (Albany):

vanbeekdulejos1771.blogspot.com
She replaces Eugene Schuler, who joined Ordwaty in June 2004. Schuler, the former directodr of tech transfer at the Universityat Albany, resignefd but will do consulting work. Mayone's task is to oversede the business side ofthe $14 100-employee institute. A Kingston native, Mayone mover to the area in the late 1960sa to attendin Troy. She was the first in her familh to attend college and went on to receiveher master'ss degree in management at . She has served as assistanyt dean for administrationat 's School of director of finance at the and as an administratore at . "Opportunities take you in directionsI didn't imaginse when I was in college," Mayonde said.
At Albany Med she was an assistantgto Dr. Paul Davis, who was chairman of the Department of Duringthat time, Davis was puttingh in place plans to create Ordway, and Mayone assistee in developing the financial "She's a mature administrator who understands biomedicind quite well and understands interpersona l relationships and working with scientists," said Davis, who is knownj as "Pepper." Davis foundedx Ordway in 2002 with $12 millioj from the to recruit scientists to the Ordway is housed in a secure part of the Buildingt on the campus in Albany.
The building, tucked behindc the New ScotlandAvenue Armory, also houses research teamz from the , an arm of the stater Department of Health. Ordway scientists are working on biodefense-related testing drugs that will combat plague and which are considered potential weapon sfor bioterrorists. Ordway works with other researchy institutions as well as private drug Its funding comes from drug companies andfederal agencies. Mayone, who was hired six monthds ago, said her charge is to creat an administrative environment that supportsthe scientists. She said she wantzs to "build on what Gene did and cement our position so we have a stabldfinancial base.
" Ordway ranks 97th among the top researcjh institutes receiving funding from the . Ordway received $3.5 million. No. 1 on the list, , receivesd more than $100 million last The NIH funds morethan 2,000 entitiesx a year. Garrett Sanders, Ordway'ss research administrator, said the institute wants to adapt to the fundin g climate because the NIH is reducing the numberf of projectsit Dr. Vincent Verdile, dean of and executive vice presidenf for health affairs atAlbang Med, said Ordway has bridged relationshipsx among institutions.
"Not only are they bringing their own peoplw tothe table, they have set the table" for collaborationa with Albany Medical Wadsworth, Rensselaer and others, Verdile "They are adding to the milieui of new biotech to the he said. Mayone is the righr person for the job because she can work with scientistzs in various disciplines as well as fromdiffereng institutions, he said.